Inhibition of the TLR9-dependent p38 MAPK signaling pathway improves the pathogenesis of primary Sjögrens syndrome in the NOD/Ltj mouse

N Cao, H Shi, C Chen, L Zheng, C Yu

Article ID: 4003
Vol 35, Issue 3, 2021
DOI: https://doi.org/10.23812/21-154-L
Received: 9 July 2021; Accepted: 9 July 2021; Available online: 9 July 2021; Issue release: 9 July 2021

Keywords

NOD;Primary Sjögren’s syndrome;TLR9;inhibitor;p38 MAPK


References

Supporting Agencies



Copyright (c) 2021 N Cao, H Shi, C Chen, L Zheng, C Yu




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).